Subscribe to our newsletter

Professor Gjumrakch Aliev

Cellular Biology

“GALLY” International Biomedical Research Institute

Dr Gjumrakch Aliev, MD, PhD, is the President of the “GALLY” International Biomedical Research Institute Inc., based in San Antonio, USA. He also holds appointments with the University of Atlanta, USA, as a Professor of Cardiovascular, Neuropathology, Gerontology, Health Science and Healthcare Administration, and as a Leading Scientist at the Institute of Physiologically Active Compounds, Russian Academy of Sciences.

He received his MD cum laude in 1982 from the Baku Medical University, Azerbaijan (then the USSR). He later accomplished his PhD cum laude in Cardiovascular Diseases from the prestigious Russian Academy of Medical Sciences, Moscow, in 1988. He received postdoctoral training from Professor G. Burnstock at University College London, UK.

He has authored and coauthored more than 500 publications in the fields of neurodegenerative disease research (Alzheimer's disease), cardio- and cerebrovascular disease, cancer, and electron microscopy. He is a teacher, scholar, and a renowned scientist in the areas of cellular molecular physiology, cardiovascular, and neurodegeneration-mediated pathologies including Alzheimer's disease (AD). He is nationally and internationally reputed in his area.

Gjumrakch’s accomplishments in the area of biochemistry and cellular biology have had tremendous implications for drug design towards CNS Neurological Disorders, AD, cancer, and cerebrovascular and neurodegeneration related pathologies. He is a world-renowned expert in electron microscopy. His work has been published in numerous prestigious journals such as Nature Clinical Cardiology, the Journal of Neuroscience, Scientific Reports, Circulation Research, the New England Journal of Medicine, Blood, the Journal Cellular and Molecular Medicine, Atherosclerosis, CNS Neurological Disorders & Drug Targets, the International Journal of Biochemistry and Cell Biology, and many others which reflect his leading role in his research areas.

He is currently the Editor-in-Chief of Central Nervous System Agents in Medicinal Chemistry, Applied Cell Biology, the World Journal of Neuroscience, the Open Journal of Psychiatry, the Journal of Aging Science, Cardiovascular & Hematological Agents in Medicinal Chemistry, Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry, which demonstrates the quality and quantity of the work he has accomplished in the areas of cellular and molecular biology as well as aged associated clinical sciences. He is one of most cited authors in his fields with high impact factors.